Streptozotocin (STZ)-induced Type 1 Diabetes Model Development
Type 1 diabetes (T1D) is a chronic autoimmune condition characterized by the body's own immune system attacking and destroying insulin-producing beta cells in the pancreas. This leads to an absolute deficiency of insulin, a hormone essential for regulating blood glucose levels.
The prevalence of T1D has been increasing globally, emphasizing the need for effective therapeutic interventions. To develop these therapeutics, a reliable and representative model of T1D is crucial. This is where the streptozotocin (STZ)-induced type 1 diabetes model development services offered by Protheragen come into play.
Download
Our Advantages
- State-of-the-art technology and advanced equipment
- Expert technical assistance
- Rigorous quality assurance and testing protocols
- Meticulous planning and transparent operational procedures
- Creative and adaptable solutions
- Dependable and esteemed collaborator
If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
Resource Download Request
Please complete the form to download the requested resources.